Entourage Health Corp.
ETRGF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | 0.01 | -0.00 |
| FCF Yield | -295.44% | -524.71% | -147.98% | -73.11% |
| EV / EBITDA | -7.21 | -2.84 | -3.59 | -2.41 |
| Quality | ||||
| ROIC | -149.63% | -156.90% | -28.30% | -30.60% |
| Gross Margin | 9.11% | -48.64% | -27.71% | -82.24% |
| Cash Conversion Ratio | 0.22 | 0.24 | 0.38 | 0.40 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.24% | 11.58% | 26.63% | 54.67% |
| Free Cash Flow Growth | 64.10% | -4.44% | 17.72% | 41.75% |
| Safety | ||||
| Net Debt / EBITDA | -7.03 | -2.70 | -2.88 | -1.29 |
| Interest Coverage | -0.88 | -3.04 | -3.33 | -8.03 |
| Efficiency | ||||
| Inventory Turnover | 3.70 | 4.11 | 1.78 | 1.64 |
| Cash Conversion Cycle | 112.61 | 112.86 | 236.18 | 198.06 |